Article
Divergence Between The EPO And The UPC On Inventive Step Of A Medical Use
Last summer, we reported on the UPC's first ever revocation decision, UPC_1/2023, which concluded that Amgen's patent (EP 3666797) lacked an inventive step.
J A Kemp LLP